Association of kidney function and albuminuria with prevalent and incident hypertension: The atherosclerosis risk in communities (ARIC) study

American Journal of Kidney Diseases

Volumn 65, Issue 1, 2015, Pages 58-66

  Huang, Minxuan ^a   Matsushita, Kunihiro ^a   Sang, Yingying ^a   Ballew, Shoshana H ^a   Astor, Brad C ^b   Coresh, Josef ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Albuminuria; Cohort study; Decreased kidney function; Incident hypertension; Kidney damage; Kidney filtration markers; Prevalent hypertension; Renal impairment

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; INCIDENT HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PREVALENT HYPERTENSION; PROSPECTIVE STUDY; ATHEROSCLEROSIS; BLOOD; COMPLICATION; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; UNITED STATES; URINE;

AGED; ALBUMINURIA; ATHEROSCLEROSIS; BETA 2-MICROGLOBULIN; BIOMARKERS; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; HUMANS; HYPERTENSION; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES;

EID: 84922430713     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.06.025     Document Type: Article

References (47)

1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation. 2013;127(1): 143-152
2. O'Brien E, Beevers G, Marshall H. ABC of Hypertension. London, UK: BMJ Books; 1995
3. Carretero OA, Oparil S. Essential hypertension. Part I: Definition and etiology. Circulation. 2000;101(3):329-335
4. Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc. 2002; 94(8 Suppl):7S-15S
5. Andoh TF, Johnson RJ, Lam T, Bennett WM. Subclinical renal injury induced by transient cyclosporine exposure is associated with salt-sensitive hypertension. Am J Transplant. 2001; 1(3):222-227
6. Zhang W, Victor RG. Calcineurin inhibitors cause renal afferent activation in rats: A novel mechanism of cyclosporineinduced hypertension. Am J Hypertens. 2000;13(9):999-1004
7. Vaziri ND, Ni Z, Zhang YP, Ruzics EP, Maleki P, Ding Y. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int. 1998;54(2): 482-491
8. Skov K, Nyengaard JR, Korsgaard N, Mulvany MJ. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens. 1994;12(12):1373-1376
9. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: The role of fetal programming. Hypertension. 2006;47(3):502-508
10. Abitbol CL, Rodriguez MM. The long-term renal and cardiovascular consequences of prematurity. Nat Rev Nephrol. 2012;8(5):265-274
11. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003;348(2):101-108
12. Kestenbaum B, Rudser KD, de Boer IH, et al. Differences in kidney function and incident hypertension: The Multi-Ethnic Study of Atherosclerosis. Ann Intern Med. 2008;148(7):501-508
13. Wang TJ, Evans JC, Meigs JB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005;111(11):1370-1376
14. Brantsma AH, Bakker SJ, De ZD, De Jong PE, Gansevoort RT. Urinary albumin excretion as a predictor of the development of hypertension in the general population. J Am Soc Nephrol. 2006;17(2):331-335
15. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol. 2008;19(10):1983-1988
16. Palatini P, Mormino P, Mos L, et al. Microalbuminuria, renal function and development of sustained hypertension: A longitudinal study in the early stage of hypertension. J Hypertens. 2005;23(1):175-182
17. Takase H, Dohi Y, Toriyama T, et al. Evaluation of risk for incident hypertension using glomerular filtration rate in the normotensive general population. J Hypertens. 2012;30(3):505-512
18. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20-29
19. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9): 604-612
20. Filler G, Priem F, Lepage N, et al. Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem. 2002;48(5):729-736
21. Woitas RP, Stoffel-Wagner B, Poege U, Schiedermaier P, Spengler U, Sauerbruch T. Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem. 2001;47(12): 2179-2180
22. Astor BC, Shafi T, Hoogeveen RC, et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59(5):653-662
23. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687-702
24. Eriksson H, Caidahl K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea-validation of a scoring test for clinical-epidemiological use: The study of men born in 1913. Eur Heart J. 1987;8(9):1007-1014
25. Wilhelmsen L, Eriksson H, Svardsudd K, Caidahl K. Improving the detection and diagnosis of congestive heart failure. Eur Heart J. 1989;10(suppl C):13-18
26. Levey AS, Coresh J, Greene T, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766-772
27. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137-147
28. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. Chapter 1: Definition and classification of CKD. Kidney Int Suppl. 2013;3:19-62
29. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252
30. Morigi M, Macconi D, Zoja C, et al. Protein overloadinduced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol. 2002;13(5):1179-1189
31. Wang Y, Rangan GK, Tay YC, Wang Y, Harris DC. Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol. 1999;10(6):1204-1213
32. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-Reactive protein and the risk of developing hypertension. JAMA. 2003;290(22):2945-2951
33. Dhaun N, Webb DJ, Kluth DC. Endothelin-1 and the kidney-beyond BP. Br J Pharmacol. 2012;167(4):720-731
34. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32(4): 219-226
35. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol. 2004;44(8):1636-1640
36. Boggia J, Thijs L, Li Y, et al. Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations. Hypertension. 2013;61(1): 18-26
37. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354(16):1685-1697
38. Correa TD, Vuda M, Takala J, Djafarzadeh S, Silva E, Jakob SM. Increasing mean arterial blood pressure in sepsis: effects on fluid balance, vasopressor load and renal function. Crit Care. 2013;17(1):R21
39. Dogan MH, Karadag B, Ozyigit T, Kayaoglu S, Ozturk AO, Altuntas Y. Correlations between sarcopenia and hypertensive target organ damage in a Turkish cohort. Acta Clin Belg. 2012;67(5):328-332
40. Roubenoff R. Sarcopenic obesity: The confluence of two epidemics. Obes Res. 2004;12(6):887-888
41. Ochi M, Kohara K, Tabara Y, et al. Arterial stiffness is associated with low thigh muscle mass in middle-aged to elderly men. Atherosclerosis. 2010;212(1):327-332
42. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol. 2005;68:123-148
43. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3):533-553
44. Bertovic DA, Waddell TK, Gatzka CD, Cameron JD, Dart AM, Kingwell BA. Muscular strength training is associated with low arterial compliance and high pulse pressure. Hypertension. 1999;33(6):1385-1391
45. Liabeuf S, Lenglet A, Desjardins L, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney Int. 2012;82(12):1297-1303
46. Shinkai S, Chaves PH, Fujiwara Y, et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: Comparison with cystatin C and C-reactive protein. Arch Intern Med. 2008;168(2):200-206
47. Bower JK, Appel LJ, Matsushita K, et al. Glycated hemoglobin and risk of hypertension in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2012;35(5):1031-1037.